Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.8K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.8K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

1.0K
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.5K
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

94
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
94
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

2.0K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Building behaviour change systems for antimicrobial resistance response in Nigeria by leveraging insights from mass gatherings awareness efforts (2017-2023).

Mass gathering medicine (Amsterdam, Netherlands)·2026
Same author

Translation and validation of the Igbo version of the Warwick-Edinburgh Mental Well-being Scale in Nigeria.

International health·2026
Same author

Examining community perspectives on integrated service delivery for tuberculosis, mental health and substance use disorder in Nigeria: A qualitative study.

PloS one·2026
Same author

Environmental-demographic determinants associated with tuberculosis prevalence in seven African countries: an aggregated dataset analysis.

EClinicalMedicine·2026
Same author

How sustainable are self-help interventions in the post-funding period? Qualitative findings from integrated leprosy communities in Nigeria.

International health·2025
Same author

Evaluating effectiveness of self-help groups in reduction of stigma in patients with neglected tropical diseases in Southern Nigeria: A cluster randomised study.

PloS one·2025

Related Experiment Video

Updated: May 4, 2026

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
10:32

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice

Published on: March 23, 2014

18.2K

Leprosy situation in Nigeria.

Sunday Udo1, Joseph Chukwu2, Joshua Obasanya3

  • 1The Leprosy Mission-Nigeria, House No. C83/C84, Fort Royal Homes Estate, Lugbe, FCT, Abuja, Nigeria. sundayu@tlmnigeria.org

Leprosy Review
|January 17, 2014
PubMed
Summary

Leprosy remains a public health concern in Nigeria, with 4000 new cases annually. Reorganizing leprosy control services is crucial to reduce disease burden and improve care, despite declining resources and expertise.

More Related Videos

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA
09:39

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA

Published on: July 15, 2011

26.6K
A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
12:22

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

Published on: December 30, 2012

24.5K

Related Experiment Videos

Last Updated: May 4, 2026

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
10:32

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice

Published on: March 23, 2014

18.2K
DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA
09:39

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA

Published on: July 15, 2011

26.6K
A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
12:22

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

Published on: December 30, 2012

24.5K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Leprosy continues to be a significant public health issue in Nigeria, with 4000 new cases detected yearly.
  • A notable 12% Grade 2 disability rate and nearly 10% child ratio among new cases highlight the disease's impact.
  • Challenges include low endemicity, reduced funding for leprosy control, and a diminishing pool of expertise.

Purpose of the Study:

  • To address the ongoing public health challenge of leprosy in Nigeria.
  • To propose a reorganization of leprosy control services.
  • To ensure sustained quality care for individuals affected by leprosy.

Main Methods:

  • This study is a review of the current leprosy control strategies in Nigeria.
  • Analysis of epidemiological data on new case detection, disability rates, and child involvement.
  • Assessment of resource allocation and expertise availability in the leprosy control program.

Main Results:

  • Despite declining endemicity, leprosy control faces challenges from reduced budgets and loss of expertise.
  • High rates of Grade 2 disability and significant child participation in new cases indicate persistent transmission and impact.
  • Current control services require strategic reorganization to meet evolving challenges.

Conclusions:

  • Nigeria must adapt its leprosy control services to current realities, including low endemicity and resource constraints.
  • Reorganization is essential to effectively reduce the leprosy burden and guarantee high-quality care.
  • Proactive strategies are needed to retain expertise and secure adequate funding for sustained leprosy control efforts.